Protein@Cyanine‐Based NIR‐II Lymphography Enables the Supersensitive Visualization of Lymphedema and Tumor Lymphatic Metastasis
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202301051 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Jiajun Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, First Hospital of Jilin University, Changchun, 130021, P. R. China. Hauptthemen laut MEDLINE: Lymphedema, Lymphatic Diseases, Lymphatic Vessels. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Visualization of the lymphatic system is clinically indispensable for the diagnosis and/or treatment of lymphatic diseases. Although indocyanine green (ICG) lymphography becomes an alternate imaging modality compared to traditional lymphoscintigraphy, it is still far from ideal due to the insufficient detection depth and low spatiotemporal resolution. Herein, protein@cyanine probes are rationally developed to solve the limitations of the current near‐infrared‐I (NIR‐I) lymphography. The protein@cyanine probes are synthesized following a chlorine‐containing dye‐labeling strategy based on structure‐selectivity (facile covalent binding between the dye and protein with a 1:1 molar ratio). As expected, the probes display exceptional NIR‐II imaging ability with much‐improved imaging contrast/resolution and controllable pharmacokinetics, superior to the clinical ICG. The protein@cyanine probes locate lymph nodes and delineate lymphatic vessels with super‐high sensitivity and signal‐to‐background ratio, enabling real‐time diagnosing lymphatic diseases such as lymphedema and tumor lymphatic metastasis. In particular, the NIR‐II lymphography provides an opportunity to discover the disparate morbidity rate of primary lymphedema in different types of mice. Given the fact of lacking clinically transferable NIR‐II probes, this work not only provides a promising strategy for enriching of the current library of NIR‐II probes, but also promotes the clinical translation of NIR‐II lymphography technology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Joint Laboratory of Opto-Functional Theranostics in Medicine and Chemistry, First Hospital of Jilin University, Changchun, 130021, P. R. China.
- State Key Laboratory of Supramolecular Structure and Materials, Center for Supramolecular Chemical Biology, College of Chemistry, Jilin University, Changchun, 130012, P. R. China.
ORCID-Profile: Shoujun Zhu
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Xu, J., Du, Y., Han, T., Zhu, N., & Zhu, S. (2023). Protein@Cyanine‐Based NIR‐II Lymphography Enables the Supersensitive Visualization of Lymphedema and Tumor Lymphatic Metastasis. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301051
Vancouver
Xu J, Du Y, Han T, Zhu N, Zhu S. Protein@Cyanine‐Based NIR‐II Lymphography Enables the Supersensitive Visualization of Lymphedema and Tumor Lymphatic Metastasis. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301051
BibTeX
@article{Xu2023,
author = {Xu, Jiajun and Du, Yijing and Han, Tianyang and Zhu, Ningning and Zhu, Shoujun},
title = {Protein@Cyanine‐Based NIR‐II Lymphography Enables the Supersensitive Visualization of Lymphedema and Tumor Lymphatic Metastasis},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202301051}
}
EUVIMED